|Articles|April 25, 2023
Discussing Challenges in mRNA Therapeutics with Phil Challis (INTERPHEX 2023)
Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics.
Advertisement
Phil Challis, vice-president of product development at eTheRNA, discusses four of the major challenges in working with mRNA therapeutics. Some topics he touches on include; what makes a good RNA construct; making RNA more tolerable; storage and distribution of lipid nanoparticles; and more.
For more INTERPHEX 2023 video content, check
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
3
What Jideytro's Approval Means for Drug Developers
4
Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates
5